SEC Form 4/A · accession 0001615774-18-008752
Emmaus Life Sciences, Inc. · EMMA
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
This is an amendment (Form 4/A). It replaces an earlier filing for the same period.
Reporting owner
John Pappajohn
Director
Period of report
Aug 28, 2018
Accepted (ET)
Aug 28, 2018 · 9:37 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000822370
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Aug 28, 2018 | P | 50,000 | $1.62 | A | 617,790 | D | |
| Common Stock | Aug 28, 2018 | P | 50,000 | $1.63 | A | 667,790 | D |
Table II — derivative securities
No Table II lines on this filing.
Remarks
This Form 4/A corrects a Form 4 filed earlier today (8/28/18).